Join our newsletter

Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM

APILAM informs you that the personal data that you provide to us by filling in this form will be treated by APILAM as responsible for this web. The purpose of the collection and processing of personal data that we request is to manage the registration of this subscription and send periodic bulletins with information and prospective offer of products or services.

Legitimation: Consent of the interested party

As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).

The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.

You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.

You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.

Last update Oct. 12, 2022

Lentostamin™

High Risk

Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.

Lentostamin is a tradename that contains several active ingredients in its composition:

Carbinoxamine Maleate (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Mepyramine (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Phenylpropanolamine; Phenylpropanolamine Hydrochloride ( Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.)

Since each active ingredient of this product may have a different level of risk for breastfeeding, we establish that of the product with higher risk.

For more information (pharmacokinetics, references, ...) tap each active ingredient.

Note: The composition of certain tradenames varies in each country. Please, make sure this is the composition of the tradename you are looking for..

Alternatives

Carbinoxamine Maleate

Cetirizine Hydrochloride ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Desloratadine ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Fexofenadine Hydrochloride ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Loratadine ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Mepyramine

Cetirizine Hydrochloride ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Loratadine ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Phenylpropanolamine; Phenylpropanolamine Hydrochloride

Cetirizine Hydrochloride ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Desloratadine ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Hypocaloric Diet ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Liraglutide ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Maternal Sport ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Orlistat (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Pseudoephedrine (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)

Very Low Risk

High Risk

Very High Risk

Very Low Risk

High Risk

Very High Risk

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Lentostamin™

High Risk

Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.

Alternatives

Carbinoxamine Maleate

Mepyramine

Phenylpropanolamine; Phenylpropanolamine Hydrochloride

Total visits

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?